Treatment of age-related macular degeneration: focus on ranibizumab

Treatment of age-related macular degeneration: focus on ranibizumab

Martin S Spitzer, Focke Ziemssen, Karl U Bartz-Schmidt, Faik Gelisken, Peter SzurmanTuebingen University Eye Center, University of Tuebingen, GermanyAbstract: Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms of VEGF-A, significantly slows down loss of vision and causes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martin S Spitzer, Focke Ziemssen, Karl U Bartz-Schmidt, Faik Gelisken, Peter Szurman
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/808111db7fc941a4b85f538425fd4db2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares